Author

Yoshikiyo Ito

Observed name: Ito, Yoshikiyo

Observed institutions: Kyushu University, Hamanomachi Hospital, Imamura Hospital, Beppu Medical Center, Harasanshin Hospital, Kyushu University Beppu Hospital

ORCID: 0000-0003-0331-4630

Observed ORCID: 0000-0003-0331-4630

OpenAlex ID: A5109514611

Genetic evolution and clinical impact in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae

2011 · Yong Chong, Yoshikiyo Ito, et al. · Infection Genetics and Evolution · 123

Community spread of extended-spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a long-term study in Japan

2013 · Yong Chong, Shinji Shimoda, et al. · Journal of Medical Microbiology · 77

Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data

2020 · Yasuo Mori, Fumiaki Jinnouchi, et al. · Bone Marrow Transplantation · 68

Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies

2011 · Yong Chong, Hiroko Yakushiji, et al. · International Journal of Infectious Diseases · 68

Nilotinib exacerbates diabetes mellitus by decreasing secretion of endogenous insulin

2012 · Yoshikiyo Ito, Toshihiro Miyamoto, et al. · International Journal of Hematology · 42

Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies

2010 · Yong Chong, Hiroko Yakushiji, et al. · International Journal of Infectious Diseases · 42

PDF

Fatal candidemia caused by azole-resistant Candida tropicalis in patients with hematological malignancies

2012 · Yong Chong, Yoshikiyo Ito, et al. · Journal of Infection and Chemotherapy · 36

Clinical features and outcome of X‐linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis

2012 · Hirokazu Kanegane, Xi Yang, et al. · Pediatric Allergy and Immunology · 35

X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis

2005 · Hirokazu Kanegane, Yoshikiyo Ito, et al. · American Journal of Hematology · 35

PDF

Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation

2012 · Takahiro Shima, Toshihiro Miyamoto, et al. · Blood · 32

Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity

2013 · Yong Chong, Shinji Shimoda, et al. · PLoS ONE · 30

PDF

Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis

2014 · Yong Chong, Shinji Shimoda, et al. · PLoS ONE · 24

PDF

E pstein‐ B arr virus‐positive diffuse large B ‐cell primary central nervous system lymphoma associated with organized chronic subdural hematoma: A case report and review of the literature

2015 · Katsuharu Kameda, Tadahisa Shono, et al. · Pathology International · 22

Higher incidence of injection site reactions after subcutaneous bortezomib administration on the thigh compared with the abdomen

2012 · Tomohiko Kamimura, Toshihiro Miyamoto, et al. · European Journal Of Haematology · 22

Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation

2012 · Tomohiko Kamimura, Toshihiro Miyamoto, et al. · International Journal of Hematology · 22

Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma

2013 · Toshihiro Miyamoto, Goichi Yoshimoto, et al. · International Journal of Hematology · 21

Safety and Seropositivity after Live Attenuated Vaccine in Adult Patients Receiving Hematopoietic Stem Cell Transplantation

2019 · Takatoshi Aoki, Tomohiko Kamimura, et al. · Transplantation and Cellular Therapy · 14

PDF

Predictors of impaired antibody response after SARS‐CoV ‐2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study

2022 · Yasuo Mori, Naoyuki Uchida, et al. · American Journal of Hematology · 13

Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis

2017 · Yong Chong, Shinji Shimoda, et al. · Infection and Drug Resistance · 13

PDF

Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

2012 · Katsuto Takenaka, Koji Nagafuji, et al. · International Journal of Hematology · 11

Recovery of physical function, muscle mass, and quality of life in patients undergoing allogeneic hematopoietic stem cell transplantation

2024 · Takahiro Takekiyo, Atae Utsunomiya, et al. · BLOOD CELL THERAPY / The official journal of APBMT · 9

PDF

Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients

2014 · Shuichiro Takashima, Toshihiro Miyamoto, et al. · International Journal of Hematology · 9

Injection site reaction after subcutaneous administration of bortezomib in Japanese patients with multiple myeloma

2012 · Tomohiko Kamimura, Toshihiro Miyamoto, et al. · International Journal of Hematology · 9

2002 · Akihiko Numata, Kazuya Shimoda, et al. · British Journal of Haematology · 9

IKZF1plus alterations are not associated with outcomes in Philadelphia‐positive acute lymphoblastic leukemia patients enrolled in the FBMTG ALL / MRD2008 trial

2023 · Yoshikiyo Ito, Hidetoshi Ozawa, et al. · European Journal Of Haematology · 7

PDF

Works count: 66

Citation count: 873

H-index: 16

I10-index: 20